Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 15, 2002BloodOpen Access

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study

View Full Paper
Ask AI
Bookmark
Share

Authors

Pier Mannuccio MannucciPier Mannuccio MannucciUniversità Cattolica del Sacro CuoreJCJuan ChediakAdvocate Illinois Masonic Medical CenterWHWahid T. HannaUniversity of Tennessee Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mannucci et al. (2002) studied this question.

synapsesocial.com/papers/6a945f6e81fc78f010707cf8https://doi.org/10.1182/blood.v99.2.450
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Recommended Protocol for the Study of the Ex Vivo Biological Effects of Virus-Inactivated Plasma Concentrates in Patients with von Willebrand Disease1992 · 11 citations
  2. 2Epidemiological investigation of the prevalence of von Willebrand's disease1987 · 1,003 citations
  3. 3Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis1996 · 57 citations